Chinese patent medicine as a complementary and alternative therapy for type 2 diabetes mellitus: A scoping review
Complementary Therapies in Medicine · 2024
DOI: 10.1016/j.ctim.2024.103014 ↗Kurz gefasst
Scoping Review in der Zeitschrift Complementary Therapies in Medicine, 2024. Verfasst von Hai-Zhu Zheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Acupuncture and Massage, Changchun University of Chinese Medicine, Changchun, Jilin, China; Center for Evidence-based Chinese Medicine, In…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Drugs, Chinese Herbal, Complementary Therapies, Chlorobenzenes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Administration of Traditional Chinese Medicine of Jilin Province, Natural Science Foundation of Jilin Province.
Themen: Diabetes mellitus
Abstract (Originalsprache)
OBJECTIVE: This scoping review aims to document Chinese Patent Medicines (CPMs) for Type 2 Diabetes Mellitus, explore whether CPMs can improve patients' health outcomes, and set priorities in addressing research gaps in this area. METHODS: Following the framework of PRISMA-SCr, we proposed the research questions based on PICOS principle, and searched the CPMs for T2DM from three drug lists, followed by a systematic search of the literature in eight databases from their inception to June 22, 2023. Then, we developed the eligibility criteria and systematically reviewed the relevant studies, retained the studies about CPMs for T2DM, extracted the related data, and identified the differences across studies in structured charts. RESULTS: A total of 25 types of CPMs were extracted from the three drug lists. Radix astragali appeared most frequently (19 times) among the herbal medicinal ingredients of CPMs. A total of 449 articles were included in the full-paper analysis ultimately, all of which were about 20 types of CPMs, and there were no related reports on the remaining five CPMs. Except about a quarter (25.39 %, 114/449) using CPMs alone, the remaining studies all involved the combination with oral hypoglycemics for T2DM. Biguanides are the most common drugs used in combination with CPMs (50.14 %, 168/335). Fasting plasma glucose (FPG) is the most frequently reported outcomes in efficacy evaluation (82.41 %, 370/449). CONCLUSION: There are a total of 25 types of CPMs currently available for T2DM patients. However, the volume of related evidence on these CPMs varies. It is necessary to standardize the combined use of CPMs and conventional medicine and select appropriate outcomes in future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Acupuncture and Massage, Changchun University of Chinese Medicine, Changchun, Jilin, China; Center for Evidence-based Chinese Medicine, Institute of Basic Research in Clinical Medicine, China Academy of Chine…
- EBM office, the Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin, China.
- College of Acupuncture and Massage, Changchun University of Chinese Medicine, Changchun, Jilin, China.
- College of Nursing, Changchun University of Traditional Chinese Medicine, Changchun, Jilin, China.
- Institute of Acupuncture and Massage, Northeast Asia Research Institute of Traditional Chinese Medicine, Changchun, Jilin, China.
- Changchun University of Chinese Medicine, Changchun, Jilin, China. Electronic address: ccwhf@126.com.
Förderung
- National Natural Science Foundation of China
- Administration of Traditional Chinese Medicine of Jilin Province
- Natural Science Foundation of Jilin Province
- Anhui University of Chinese Medicine
Zitieren
APA
Zheng, H. Z., Chang, T. Y., Peng, B., Ma, S. Q., Zhong, Z., Cao, J. Z., Yao, L., Li, M. Y., Wang, H. F., & Liao, X. (2024). Chinese patent medicine as a complementary and alternative therapy for type 2 diabetes mellitus: A scoping review. Complementary Therapies in Medicine. https://doi.org/10.1016/j.ctim.2024.103014
Vancouver
Zheng HZ, Chang TY, Peng B, Ma SQ, Zhong Z, Cao JZ, et al. Chinese patent medicine as a complementary and alternative therapy for type 2 diabetes mellitus: A scoping review. Complementary Therapies in Medicine. 2024. doi:10.1016/j.ctim.2024.103014
BibTeX
@article{Zheng2024,
author = {Zheng, Hai-Zhu and Chang, Tian-Ying and Peng, Bo and Ma, Shi-Qi and Zhong, Zhen and Cao, Jia-Zhen and Yao, Lin and Li, Meng-Yuan and Wang, Hong-Feng and Liao, Xing},
title = {Chinese patent medicine as a complementary and alternative therapy for type 2 diabetes mellitus: A scoping review},
journal = {Complementary Therapies in Medicine},
year = {2024},
doi = {10.1016/j.ctim.2024.103014}
}
EUVIMED